
1 December 2025 - Eli Lilly announced Zepbound (tirzepatide) single dose vials will now be available at lower prices on LillyDirect, the company’s digital health care platform.
This update builds on Lilly’s on-going efforts to lower out of pocket costs for people living with obesity in the US.